These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 34920654)
21. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses. Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467 [TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Fu QL; Chow YY; Sun SJ; Zeng QX; Li HB; Shi JB; Sun YQ; Wen W; Tse HF; Lian Q; Xu G Allergy; 2012 Oct; 67(10):1215-22. PubMed ID: 22882409 [TBL] [Abstract][Full Text] [Related]
23. L-Glutamine in vitro Modulates some Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells. Dos Santos GG; Hastreiter AA; Sartori T; Borelli P; Fock RA Stem Cell Rev Rep; 2017 Aug; 13(4):482-490. PubMed ID: 28593472 [TBL] [Abstract][Full Text] [Related]
24. An insight into the role of magnesium in the immunomodulatory properties of mesenchymal stem cells. da Silva Lima F; da Rocha Romero AB; Hastreiter A; Nogueira-Pedro A; Makiyama E; Colli C; Fock RA J Nutr Biochem; 2018 May; 55():200-208. PubMed ID: 29554498 [TBL] [Abstract][Full Text] [Related]
26. Cytokines Differently Define the Immunomodulation of Mesenchymal Stem Cells from the Periodontal Ligament. Behm C; Blufstein A; Gahn J; Nemec M; Moritz A; Rausch-Fan X; Andrukhov O Cells; 2020 May; 9(5):. PubMed ID: 32423044 [TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory properties of umbilical cord vein mesenchymal stromal cells influenced by gestational age and in vitro expansion. Abolhasani M; Rezaee MA; Mohammadi M; Ghadimi T; Mohammadi M; Rahmani MR Immunol Lett; 2018 Feb; 194():62-68. PubMed ID: 29175314 [TBL] [Abstract][Full Text] [Related]
28. Potential surrogate quantitative immunomodulatory potency assay for monitoring human umbilical cord-derived mesenchymal stem cells production. Teng SW; Sung HY; Wen YC; Chen SY; Lovel R; Chang WY; Wu TB; Hsuan YC; Lin W Cell Biol Int; 2021 May; 45(5):1072-1081. PubMed ID: 33470478 [TBL] [Abstract][Full Text] [Related]
29. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes. Xu K; Ma D; Zhang G; Gao J; Su Y; Liu S; Liu Y; Han J; Tian M; Wei C; Zhang L Mol Immunol; 2021 Jul; 135():36-44. PubMed ID: 33857817 [TBL] [Abstract][Full Text] [Related]
30. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment. Cassano JM; Schnabel LV; Goodale MB; Fortier LA Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of COX-2 but not indoleamine 2,3-dioxygenase-1 enhances the immunosuppressive ability of human umbilical cord-derived mesenchymal stem cells. Li D; Han Y; Zhuang Y; Fu J; Liu H; Shi Q; Ju X Int J Mol Med; 2015 May; 35(5):1309-16. PubMed ID: 25777747 [TBL] [Abstract][Full Text] [Related]
33. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Zheng ZH; Li XY; Ding J; Jia JF; Zhu P Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486 [TBL] [Abstract][Full Text] [Related]
34. Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus. Zheng B; Zhang P; Yuan L; Chhetri RK; Guo Y; Deng D Lupus; 2020 Feb; 29(2):126-135. PubMed ID: 31870216 [TBL] [Abstract][Full Text] [Related]
35. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs. Zimmermann JA; Hettiaratchi MH; McDevitt TC Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190 [TBL] [Abstract][Full Text] [Related]
36. Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors. Javorkova E; Matejckova N; Zajicova A; Hermankova B; Hajkova M; Bohacova P; Kossl J; Krulova M; Holan V J Neuroimmune Pharmacol; 2019 Jun; 14(2):215-225. PubMed ID: 30242613 [TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory and immunogenic properties of mesenchymal stem cells derived from bovine fetal bone marrow and adipose tissue. Huaman O; Bahamonde J; Cahuascanco B; Jervis M; Palomino J; Torres CG; Peralta OA Res Vet Sci; 2019 Jun; 124():212-222. PubMed ID: 30925336 [TBL] [Abstract][Full Text] [Related]
38. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients. Mrahleh MA; Matar S; Jafar H; Wehaibi S; Aslam N; Awidi A Front Immunol; 2021; 12():732549. PubMed ID: 34650558 [TBL] [Abstract][Full Text] [Related]
39. Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources. De Schauwer C; Goossens K; Piepers S; Hoogewijs MK; Govaere JL; Smits K; Meyer E; Van Soom A; Van de Walle GR Stem Cell Res Ther; 2014 Jan; 5(1):6. PubMed ID: 24418262 [TBL] [Abstract][Full Text] [Related]
40. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro. Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]